Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.

Item
http://www.wikidata.org/entity/Q37205638
Update on the Medical Management of Gastrointestinal Behçet's Disease.Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis.Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease.Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study.Management of severe complications in Behçet's disease with TNF inhibitors.Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial.Updated treatment strategies for intestinal Behçet's disease.Brief Report: Drug-Free Long-Term Remission in Severe Behçet's Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment.Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease.What Is Vascular Behçet's Disease?
P2860

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.

Item
http://www.wikidata.org/entity/Q37205638
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infliximab therapy for intesti ...... bel, single-arm phase 3 study.
@en
Infliximab therapy for intesti ...... bel, single-arm phase 3 study.
@nl
type
label
Infliximab therapy for intesti ...... bel, single-arm phase 3 study.
@en
Infliximab therapy for intesti ...... bel, single-arm phase 3 study.
@nl
prefLabel
Infliximab therapy for intesti ...... bel, single-arm phase 3 study.
@en
Infliximab therapy for intesti ...... bel, single-arm phase 3 study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Infliximab therapy for intesti ...... bel, single-arm phase 3 study.
@en
P2093
P2860
P304
P31
P356
10.1097/MD.0000000000003863
P407
P433
P478
P577
P698
P921
P932